Metraipolis › archive › dc_49491bf644b2

Emodin Enhances Rosiglitazone's Therapeutic Profile by Dual Modulation of SREBP1-Mediated Adipogenesis and PPARγ-Driven Thermogenesis — Europe PMC PMID:41471299

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41471299
DOI
10.3390/ph18121810
License (as archived)
solo-consultazione
Archived
2026-11-08T05:08:55.037Z
SHA-256 of the archived text
9ce9696fd44b181952a07080ede7d152126c75c4e855dda742e452aaa3c25570
Stable URL of this page
https://metraipolis.com/documento/dc_49491bf644b2

How to cite

Emodin Enhances Rosiglitazone's Therapeutic Profile by Dual Modulation of SREBP1-Mediated Adipogenesis and PPARγ-Driven Thermogenesis — Europe PMC PMID:41471299 — Europe PMC (en), https://europepmc.org/article/MED/41471299 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_49491bf644b2 (Metraipolis archive dc_49491bf644b2, sha256 9ce9696fd44b181952a07080ede7d152126c75c4e855dda742e452aaa3c25570)
BibTeX
@misc{dc49491bf644b2,
  title = {Emodin Enhances Rosiglitazone's Therapeutic Profile by Dual Modulation of SREBP1-Mediated Adipogenesis and PPARγ-Driven Thermogenesis — Europe PMC PMID:41471299},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41471299},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_49491bf644b2; sha256 9ce9696fd44b181952a07080ede7d152126c75c4e855dda742e452aaa3c25570},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41471299. Agents can read the archived copy with the MCP tool read_document.